Intranasal delivery of Chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: a comprehensive review of advanced …

RM Ibrahim, M Teaima, MA El-Nabarawi… - Journal of Drug Delivery …, 2024 - Elsevier
Neurodegenerative disorders are chronic conditions related to brain malfunctions. The
presence of the blood-brain barrier creates obstacles to the management of central nervous …

The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats

N Hashemi-Firouzi, S Afshar, SS Asl… - Metabolic Brain …, 2022 - Springer
Some mineral elements exert beneficial neuroprotection, especially in the form of
nanoparticles. The aim of the present study was to evaluate the effects of selenium …

Acetylcholinesterase biosensor based on reduced graphene oxide–carbon black composite for determination of reversible inhibitors

R Shamagsumova, A Rogov, D Shurpik… - …, 2022 - Wiley Online Library
For the first time, acetylcholinesterase (AChE) biosensors based on mixed carbon
nanomaterials (electrochemically reduced graphene oxide (ERGO) and carbon black (CB) …

Inhibition of tau protein aggregation by a chaperone-like β-boswellic acid conjugated to gold nanoparticles

M Gharb, A Nouralishahi, A Riazi, G Riazi - ACS omega, 2022 - ACS Publications
A potential therapeutic strategy to inhibit tau protein aggregation in neurons has substantial
effects on preventing or controlling Alzheimer's disease (AD). In this work, we designed a …

Nano-Theranostics approaches and Mitochondrial Targeted Drug Delivery: Alzheimer's disease therapeutic interventions

L Chacko, S Nag, S Dewanjee, S Ghosh… - 2022 - preprints.org
One of the most frequent brain diseases, Alzheimer's is defined by poor cognitive function
brought on by the build-up of Beta Amyloid plaques and the gradual death of neurons …